ArticleFrontiers in oncology2026

Bridging practice and precision: a quantitative HER2 protein assay ready for clinical use in guiding trastuzumab deruxtecan therapy.

Junmei Hao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.